Hypersensitivity, Immediate Completed Phase 3 Trials for Tyrosine (DB00135)

Also known as: Type I Hypersensitivity / Immediate Hypersensitivity / Hypersensitivity type I / Hypersensitivity type I NOS / Immediate hypersensitivity reaction

IndicationStatusPhase
DBCOND0031076 (Hypersensitivity, Immediate)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00414141Efficacy and Safety/Tolerability of Grass MATA MPLTreatment